-transparent.png){kind=logo}
Some new 4-quinazolinones were prepared. Their antiplatelet activity was evaluated in vitro with respect to aggregation induced by ADP, collagen, arachidonic acid and the platelet serotonin release reaction. Most molecules showed an inhibiting power similar to that of acetylsalicylic acid under the same conditions, and even greater when aggregation was induced by ADP. Reduction of the 4-quinazolinone derivatives to their 1,2,3,4-tetrahydroquinazoline homologues produced an increase in platelet inhibitory action except when ADP is the inductor.
Related Publications
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
February 2017,
Archiv der Pharmazie,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
February 2004,
Archiv der Pharmazie,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
July 2011,
Research in pharmaceutical sciences,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
July 2007,
Yao xue xue bao = Acta pharmaceutica Sinica,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
January 2012,
Research in pharmaceutical sciences,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
January 1981,
Arzneimittel-Forschung,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
August 1988,
Chemical & pharmaceutical bulletin,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
April 2005,
Bioorganic & medicinal chemistry letters,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
December 2014,
Organic and medicinal chemistry letters,
D Gravier, and
J P Dupin, and
F Casadebaig, and
G Hou, and
M Boisseau, and
H Bernard
October 2010,
Journal of advanced pharmaceutical technology & research,
